Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of atezolizumab-based therapy in prior Genentech/Roche trials
jRCT2080224989Phase 3Recruiting
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Dec 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 3, open-label trial of atezolizumab in cancer (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Started Dec 2019; status: recruiting.
02
Drugs
atezolizumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080224989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224989.